While some regulatory pathways have been identified, particularly the ubiquitination-mediated degradation of ASCL1, the contribution of the post-translational regulation of these transcription factors as well as their physiological roles in SCLC pathogenesis remains largely unknown. This evidence concerns the gene ASCL1 and small cell lung carcinoma.